Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Outcome of children treated for relapsed acute myeloid leukemia in Central America.

Marjerrison S, Antillon F, Bonilla M, Fu L, Martinez R, Valverde P, Vasquez R, Howard SC, Ribeiro RC, Sung L.

Pediatr Blood Cancer. 2014 Jul;61(7):1222-6. doi: 10.1002/pbc.24942. Epub 2014 Jan 17.

PMID:
24443303
2.

Outcome of children treated for relapsed acute lymphoblastic leukemia in Central America.

Marjerrison S, Antillon F, Fu L, Martinez R, Vasquez R, Bonilla M, Howard SC, Sung L.

Cancer. 2013 Mar 15;119(6):1277-83. doi: 10.1002/cncr.27846. Epub 2012 Nov 16.

3.

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

Gorman MF, Ji L, Ko RH, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML.

Pediatr Blood Cancer. 2010 Sep;55(3):421-9. doi: 10.1002/pbc.22612.

PMID:
20658611
4.

Improved outcome after relapse in children with acute myeloid leukaemia.

Abrahamsson J, Clausen N, Gustafsson G, Hovi L, Jonmundsson G, Zeller B, Forestier E, Heldrup J, Hasle H; Nordic Society for Paediatric Haematology and Oncology (NOPHO)..

Br J Haematol. 2007 Jan;136(2):229-236.

PMID:
17278259
5.

[Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].

Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.

Zhongguo Dang Dai Er Ke Za Zhi. 2007 Feb;9(1):28-33. Chinese.

PMID:
17306073
6.

Long-term survey of outcome in acute promyelocytic leukemia.

Hu J, Shen Z, Sun H, Wu W, Li X, Sun G, Wang Z.

Chin Med J (Engl). 2000 Feb;113(2):107-10.

PMID:
11775530
7.

Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.

Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Sakura T, Kanamori H, Usuki K, Yamashita T, Okoshi Y, Shibayama H, Nakamae H, Mawatari M, Hatanaka K, Sunami K, Shimoyama M, Fujishima N, Maeda Y, Miura I, Takaue Y, Fukuda T.

Haematologica. 2010 Nov;95(11):1857-64. doi: 10.3324/haematol.2010.027516. Epub 2010 Jul 15.

8.

Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.

Navarrete M, Rossi E, Brivio E, Carrillo JM, Bonilla M, Vasquez R, Peña A, Fu L, Martinez R, Espinoza CM, Lacayo LF, Rodriguez H, Batista R, Barr R, Howard SC, Ribeiro RC, Masera G, Biondi A, Conter V, Valsecchi MG.

Pediatr Blood Cancer. 2014 May;61(5):803-9. doi: 10.1002/pbc.24911. Epub 2013 Dec 24.

PMID:
24376115
9.

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.

Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, Zhou L, Li JM, Zeng XY, Yang RR, Yuan MM, Ren MY, Gu FY, Cao Q, Gu BW, Su XY, Chen GQ, Xiong SM, Zhang TD, Waxman S, Wang ZY, Chen Z, Hu J, Shen ZX, Chen SJ.

Blood. 1999 Nov 15;94(10):3315-24.

10.

Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China.

Xu XJ, Tang YM, Song H, Yang SL, Shi SW, Wei J.

Leuk Lymphoma. 2010 Dec;51(12):2262-9. doi: 10.3109/10428194.2010.518653. Epub 2010 Oct 7. Erratum in: Leuk Lymphoma. 2011 Mar;52(3):544.

PMID:
20929322
11.

[Outcome of haploidentical hematopoietic stem cell transplantation for refractory/relapsed acute leukemia].

Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W, Chen H, Chen YH, Wang FR, Wang JZ, Fu HX, Huang XJ.

Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):917-21. Chinese.

PMID:
23363748
12.

Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.

Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Bénard A, Bordigoni P, Gandemer V, Thuret I, Dalle JH, Piguet C, Pautard B, Baruchel A, Leverger G; French Society of Pediatric Hematology and Immunology..

J Clin Oncol. 2003 Dec 1;21(23):4377-85.

PMID:
14645428
13.

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia.

Stahnke K, Boos J, Bender-Götze C, Ritter J, Zimmermann M, Creutzig U.

Leukemia. 1998 Oct;12(10):1534-8.

PMID:
9766496
14.

[Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children].

Chen J, Gu LJ, Tang JY, Xue HL, Pan C, Ye QD, Jiang H, Dong L, Zhou M, Wang YP.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Jun;10(3):329-32. Chinese.

PMID:
18554461
15.

Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97.

Fujita H, Asou N, Iwanaga M, Hyo R, Nomura S, Kiyoi H, Okada M, Inaguma Y, Matsuda M, Yamauchi T, Ohtake S, Izumi T, Nakaseko C, Ishigatsubo Y, Shinagawa K, Takeshita A, Miyazaki Y, Ohnishi K, Miyawaki S, Naoe T; Japan Adult Leukemia Study Group..

Cancer Sci. 2013 Oct;104(10):1339-45. doi: 10.1111/cas.12230. Epub 2013 Aug 5.

16.

Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.

Pagnano KB, Traina F, Takahashi T, Oliveira GB, Rossini MS, Lorand-Metze I, Vigorito AC, Miranda EC, De Souza CA.

Sao Paulo Med J. 2000 Nov 9;118(6):173-8.

17.

Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.

Castellino SM, Alonzo TA, Buxton A, Gold S, Lange BJ, Woods WG.

Pediatr Blood Cancer. 2008 Jan;50(1):9-16.

PMID:
17252564
18.

Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials.

Sander A, Zimmermann M, Dworzak M, Fleischhack G, von Neuhoff C, Reinhardt D, Kaspers GJ, Creutzig U.

Leukemia. 2010 Aug;24(8):1422-8. doi: 10.1038/leu.2010.127. Epub 2010 Jun 10.

PMID:
20535146
19.

Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience.

Mathews V, Balasubramanian P, Shaji RV, George B, Chandy M, Srivastava A.

Am J Hematol. 2002 Aug;70(4):292-9.

20.

Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.

Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, Guerci A, Recher C, Raffoux E, Thomas X, Leblanc T, Idres N, Cassinat B, Vey N, Chomienne C, Dombret H, Sanz M, Fenaux P, Adès L.

J Clin Oncol. 2012 May 10;30(14):1641-6. doi: 10.1200/JCO.2011.38.4560. Epub 2012 Apr 2.

PMID:
22473162

Supplemental Content

Support Center